Literature DB >> 21355860

How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis.

Shakila Thangaratinam1, Ioannis D Gallos, Neki Meah, Sa'ada Usman, Khaled M K Ismail, Khalid S Khan.   

Abstract

BACKGROUND: Maternal symptoms such as severe headache, nausea and vomiting, visual disturbances and epigastric pain have been associated with complications in women with preeclampsia.
OBJECTIVE: To determine the accuracy of maternal symptoms in predicting complications in women with preeclampsia by systematic review. DATA SOURCES: We searched MEDLINE (1951-2010), EMBASE (1980-2010), the Cochrane Library (2009) and the MEDION database. METHODS OF STUDY SELECTION: Studies which evaluated the accuracy of symptoms in women with preeclampsia for predicting complications were selected in a two-stage process. Information was extracted by two independent reviewers. We summarized accuracy with a bivariate model estimating sensitivity, specificity and area under the curve.
RESULTS: Six primary articles with 2573 women were included. The area under the curve for predicting complications for headache, epigastric pain and visual disturbances was 0.58 (95%CI 0.24-0.86), 0.70 (95%CI 0.30-0.93) and 0.74 (95%CI 0.33-0.94). The sensitivity and specificity of the symptoms in predicting adverse maternal outcomes were respectively as follows: headache 0.54 (95%CI 0.27-0.79) and 0.59 (95%CI 0.38-0.76); epigastric pain 0.34 (95%CI 0.22-0.5) and 0.83 (95%CI 0.76-0.89); visual disturbances 0.27 (95%CI 0.07-0.65) and 0.81 (95%CI 0.71, 0.88); nausea and vomiting 0.24 (95%CI 0.21, 0.27) and 0.87 (95%CI 0.85, 0.89).
CONCLUSION: The presence of symptoms is more useful in predicting complications in preeclampsia compared to their absence in excluding adverse events.
© 2011 The Authors Acta Obstetricia et Gynecologica Scandinavica© 2011 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Mesh:

Year:  2011        PMID: 21355860     DOI: 10.1111/j.1600-0412.2011.01111.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  16 in total

1.  Associating Symptom Phenotype and Genotype in Preeclampsia.

Authors:  Sandra A Founds; Eleni Tsigas; Dianxu Ren; M Michael Barmada
Journal:  Biol Res Nurs       Date:  2018-01-22       Impact factor: 2.522

2.  ACOG and local diagnostic criteria for hypertensive disorders of pregnancy (HDP) in La Paz-El Alto, Bolivia: A retrospective case-control study.

Authors:  Litzi Lazo-Vega; Lilian Toledo-Jaldin; Abraham Badner; José Luis Barriga-Vera; Melany Castro-Monrroy; Anna G Euser; Alison Larrea-Alvarado; Ian Lawrence; Carola Mérida; Rodrigo Mizutani; Yuri Pérez; Sebastian Rocabado; Manfredo Vargas; Vikram Vasan; Colleen G Julian; Lorna G Moore
Journal:  Lancet Reg Health Am       Date:  2022-01-26

3.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

4.  Prediction of Adverse Maternal Outcomes in Preeclampsia Using a Risk Prediction Model.

Authors:  Shruti Agrawal; Nandita Maitra
Journal:  J Obstet Gynaecol India       Date:  2015-11-11

Review 5.  Angiogenic factors in diagnosis, management, and research in preeclampsia.

Authors:  Sarosh Rana; S Ananth Karumanchi; Marshall D Lindheimer
Journal:  Hypertension       Date:  2013-10-28       Impact factor: 10.190

6.  Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia.

Authors:  Glenn E Palomaki; James E Haddow; Hamish R M Haddow; Saira Salahuddin; Carl Geahchan; Ana Sofia Cerdeira; Stefan Verlohren; Frank H Perschel; Gary Horowitz; Ravi Thadhani; S Ananth Karumanchi; Sarosh Rana
Journal:  Prenat Diagn       Date:  2015-02-04       Impact factor: 3.050

7.  Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models.

Authors:  Shakila Thangaratinam; John Allotey; Nadine Marlin; Julie Dodds; Fiona Cheong-See; Peter von Dadelszen; Wessel Ganzevoort; Joost Akkermans; Sally Kerry; Ben W Mol; Karl G M Moons; Richard D Riley; Khalid S Khan
Journal:  BMC Med       Date:  2017-03-30       Impact factor: 8.775

8.  Prodromal symptoms, health care seeking in response to symptoms and associated factors in eclamptic patients.

Authors:  Wondimu Gudu
Journal:  BMC Pregnancy Childbirth       Date:  2017-03-14       Impact factor: 3.007

9.  Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia.

Authors:  Sarosh Rana; Ana Sofia Cerdeira; Julia Wenger; Saira Salahuddin; Kee-Hak Lim; Steven J Ralston; Ravi I Thadhani; S Ananth Karumanchi
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

10.  Clinical and Biomarkers Difference in Prepartum and Postpartum Eclampsia.

Authors:  Yifru Berhan; Gezahegn Endeshaw
Journal:  Ethiop J Health Sci       Date:  2015-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.